Genetic Testing
Latin America · 3 shared keywords
Updated
Reviewed by Vidhi Upadhyay
Latin America Molecular Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Technology, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$2.03 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.19 Bn | — | — |
| 2025 (base) | $1.32 Bn | +$129.8 Mn | — |
| 2026 (forecast) | $1.46 Bn | +$143.9 Mn | +10.9% |
| 2027 (forecast) | $1.62 Bn | +$159.6 Mn | +23% |
| 2028 (forecast) | $1.80 Bn | +$177.0 Mn | +36.4% |
| 2029 (forecast) | $2.00 Bn | +$196.3 Mn | +51.3% |
| 2030 (forecast) | $2.21 Bn | +$217.7 Mn | +67.7% |
| 2031 (forecast) | $2.46 Bn | +$241.4 Mn | +86% |
| 2032 (forecast) | $2.72 Bn | +$267.7 Mn | +106.3% |
| 2033 (forecast) | $3.02 Bn | +$296.9 Mn | +128.8% |
| 2034 (forecast) | $3.35 Bn | +$329.3 Mn | +153.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.32 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $3.35 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 10.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Technology, application and end user (see all) |
| Key players | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Hologic, Inc. and 1 more (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Molecular diagnostics tests read DNA, RNA and proteins to find infections, cancer and inherited disease.
Key segments of the molecular diagnostics market include technology (PCR, Sequencing and Isothermal Amplification) and application (Infectious Disease, Oncology and Genetic Disease).
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the molecular diagnostics market.
Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the molecular diagnostics market room to grow.
Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the molecular diagnostics market.
The molecular diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medical devices are regulated by ANVISA (Brazil)[1], ARCSA (Ecuador)[2], COFEPRIS (Mexico)[3], ANMAT (Argentina)[4], INVIMA (Colombia)[5] and ISP (Chile)[6]. How care is paid for in some of these countries: the SUS (Brazil)[7]; public care and IESS (Ecuador)[8]; IMSS, ISSSTE and IMSS-Bienestar (Mexico)[9]; public care, obras sociales and prepaid plans (Argentina)[10]; social health insurance (EPS) (Colombia)[11]; and FONASA and ISAPREs (Chile)[12].
[1] ANVISA. Checked 14 Nov 2026.
[2] ARCSA. Checked 14 Nov 2026.
[3] COFEPRIS. Checked 14 Nov 2026.
[4] ANMAT. Checked 19 Nov 2026.
[5] INVIMA. Checked 19 Nov 2026.
[6] Institute of Public Health of Chile (ISP). Checked 19 Nov 2026.
[7] CONITEC. Checked 14 Nov 2026.
[8] Ministry of Public Health of Ecuador. Checked 14 Nov 2026.
[9] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.
[10] Superintendence of Health Services (SSSalud). Checked 19 Nov 2026.
[11] Ministry of Health and Social Protection. Checked 19 Nov 2026.
[12] FONASA. Checked 19 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how molecular diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Latin America.
From our blog
Latin America · 3 shared keywords
Latin America · 3 shared keywords
Latin America · 2 shared keywords
Latin America · 2 shared keywords
Latin America · 2 shared keywords
Latin America · 1 shared keyword
Pharmaceuticals · Latin America
Digital Health · Latin America
Healthcare Services · Latin America
Healthcare Services · Latin America
Digital Health · Latin America
Healthcare Services · Latin America